ClinicalTrials.gg
CompletedNCT07908836Updated Nov 2, 2026

PBM and Hip Fracture

An observational study in Hip Fracture, sponsored by Hospital del Rio Hortega. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Hospital del Rio Hortega · Observational

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
829
Sex
All
01

Study summary

The main objective of this study was to describe the application of PBM strategies in patients undergoing surgery for hip fractures, their outcomes between 2022 and 2024, and the factors associated with the transfusion of red blood cell concentrates. As secondary objectives, the study analysed the factors associated with surgical delay, particularly prior oral anticoagulation, as well as post-operative delirium, in-hospital complications, prolonged hospital stay and mortality at 30 days, 6 months and 1 year.

Translated with DeepL.com (free version)

02

Conditions studied

  • Hip Fracture

Browse trials for

Keywords

  • PBM
  • Mortality
03

In context

Hip Fractures

842 studies on the registry are indexed under Hip Fractures; 165 are open to participants now.

This study's enrollment of 829 is above the median of 149 across 280 observational studies indexed under Hip Fractures.

Browse Hip Fractures studies →

Lead sponsor

Hospital del Rio Hortega is the lead sponsor of 27 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

adult patients admitted for a hip fracture

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients admitted for a hip fracture And Surgical treatment between January 2022 and April 2024

Exclusion criteria

Exclusion Criteria:

  • Pathological fractures secondary to neoplasia,
  • High-energy fractures in young patients,
  • Records lacking sufficient information for the main analyses
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
829 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Application of PBM strategies in patients who have undergone surgery for a hip fracture

    Specification for the application of the PBM pillars during hospital admission.

    Time frame: length of hospital stay

Secondary outcomes

  1. post-operative delirium

    Episode of delirium documented in the hospital medical record

    Time frame: hospital admission

  2. in-hospital complications

    Time frame: hospital admission

  3. mortality

    Time frame: at 30 days, 6 months and 1 year.

07

Study locations

1 site
  • Hospital Universitario Rio Hortega
    Valladolid, Spain
08

References and documents

Individual participant data

Plan to share: No — a single-centre retrospective study to be published

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07908836
Lead sponsor
Hospital del Rio Hortega
Responsible party
Cesar Aldecoa (Head of Department Anaesthesiology, Hospital del Rio Hortega) — Principal investigator
First posted
Nov 2, 2026
Start date
Jan 1, 2022
Primary completion
May 30, 2024
Completion
May 30, 2024
Last update
Nov 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion